FEBS Letters | |
Elafin (elastase‐specific inhibitor) has anti‐microbial activity against Gram‐positive and Gram‐negative respiratory pathogens | |
Sallenave, J.-M.2  Haslett, C.2  Simpson, A.J.2  Govan, J.R.W.1  Maxwell, A.I.1  | |
[1] Cystic Fibrosis Laboratory, Department of Medical Microbiology, University of Edinburgh Medical School, Teviot Place, Edinburgh EH8 9AG, UK;Rayne Laboratory, Respiratory Medicine Unit, University of Edinburgh Medical School, Teviot Place, Edinburgh EH8 9AG, UK | |
关键词: Elafin; Human neutrophil elastase; Anti-microbial activity; Pseudomonas aeruginosa; Staphylococcus aureus; HNE; human neutrophil elastase; α1-PI; α1-protease inhibitor; SLPI; secretory leucocyte protease inhibitor; HSA; human serum albumin; TSB; tryptone soya broth; LPS; lipopolysaccharide; CF; cystic fibrosis; | |
DOI : 10.1016/S0014-5793(99)00670-5 | |
学科分类:生物化学/生物物理 | |
来源: John Wiley & Sons Ltd. | |
![]() |
【 摘 要 】
Elafin (elastase-specific inhibitor) is a low molecular weight inhibitor of neutrophil elastase which is secreted in the lung. Using synthetic peptides corresponding to full-length elafin (H2N-1AVT.....95Q-OH), the NH2-terminal domain (H2N-1AVT.....50K-OH) and the COOH-terminal domain (H2N-51PGS.....95Q-OH), we demonstrate that elafin's anti-elastase activity resides exclusively in the COOH-terminus. Several characteristics of elafin suggest potential anti-microbial activity. The anti-microbial activity of elafin, and of its two structural domains, was tested against the respiratory pathogensPseudomonas aeruginosa and Staphylococcus aureus. Elafin killed both bacteria efficiently, with 93% killing of P. aeruginosa by 2.5 μM elafin and 48% killing of S. aureus by 25 μM elafin. For both organisms, full-length elafin was required to optimise bacterial killing. These findings represent the first demonstration of co-existent anti-proteolytic and anti-microbial functions for elafin.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201912020307814ZK.pdf | 140KB | ![]() |